| |
| |
|
| Insider
Information: |
Drews Jurgen |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
10,835 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
10,835 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PDL Biopharma Inc |
PDLI |
Director |
2004-05-28 |
0 |
2004-05-27 |
0 |
Premium* |
|
|
Human Genome Sciences Inc |
HGSI |
Director |
2011-01-10 |
10,835 |
2009-04-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2011-01-10 |
4 |
A |
$25.83 |
$7,852 |
D/D |
304 |
10,835 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2010-10-11 |
4 |
A |
$29.15 |
$3,615 |
D/D |
124 |
10,531 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2010-07-12 |
4 |
A |
$25.23 |
$10,104 |
D/D |
366 |
10,407 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2010-06-30 |
4 |
OE |
$2.09 |
$300,096 |
D/D |
37,634 |
47,675 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2010-06-30 |
4 |
S |
$23.18 |
$875,761 |
D/D |
(37,634) |
10,041 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2010-06-29 |
4 |
S |
$22.80 |
$858,730 |
D/D |
(37,634) |
10,041 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2010-06-29 |
4 |
OE |
$10.69 |
$402,411 |
D/D |
37,634 |
47,675 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2010-06-28 |
4 |
OE |
$10.70 |
$425,724 |
D/D |
37,634 |
47,675 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2010-06-28 |
4 |
S |
$23.56 |
$899,139 |
D/D |
(37,634) |
10,041 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2010-04-12 |
4 |
A |
$32.86 |
$2,366 |
D/D |
72 |
10,041 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2010-01-11 |
4 |
A |
$30.82 |
$4,993 |
D/D |
162 |
9,969 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2009-12-22 |
4 |
B |
$29.66 |
$32,626 |
D/D |
1,100 |
9,807 |
2.39 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2009-10-12 |
4 |
A |
$18.50 |
$4,995 |
D/D |
270 |
8,707 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2009-07-10 |
4 |
A |
$2.53 |
$4,625 |
D/D |
1,828 |
8,437 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2009-04-10 |
4 |
A |
$0.87 |
$5,750 |
D/D |
6,609 |
6,609 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2004-05-28 |
4 |
S |
$19.52 |
$1,366,393 |
D/D |
(70,000) |
0 |
|
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2004-05-28 |
4 |
OE |
$9.69 |
$678,125 |
D/D |
70,000 |
70,000 |
|
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2004-05-27 |
4 |
S |
$19.85 |
$952,800 |
D/D |
(48,000) |
0 |
|
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2004-05-27 |
4 |
OE |
$6.64 |
$318,720 |
D/D |
48,000 |
48,000 |
|
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
